Clinical Trial Update: The Availability and Safety Study of Remimazolam Besylate for Injection on Sedation of ERAS Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update on the availability and safety of remimazolam besylate for injection used in sedation of ERAS patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Analgesia
• Postoperative Pain

Drugs mentioned

• Remimazolam Besylate for Injection (remimazolam besylate)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Analgesia, Postoperative Pain | Phase 3 | Status: UNKNOWN